Smeaglutide is popular all over the Internet, the secret is that its weight reduction effect can withstand the test.
As a GLP-1 (glucagon-like peptide-1) receptor agonist, Smeaglutide stimulates the body to produce more GLP-1.
GLP-1 is a protein secreted by human glucagon gene, widely distributed in multiple organs and tissues throughout the body, which can promote the secretion of human insulin and play a role in reducing blood sugar.
Of course, weight loss is not because GLP-1 makes insulin secretion too much and energy expenditure is accelerated, but can suppress the central nervous appetite and delay gastric emptying.
In short, GLP-1 agonists ultimately make people less hungry, so they eat less and lose weight.
"Smeaglutide" shows extremely powerful weight loss effects based on a clear weight-loss mechanism.
Based on the phase III clinical data, the weight loss in different groups ranged from 10.6% to 18.2% after 68 weeks of administration. During this period, participants will only need to take Smeaglutide injections once a week, and no other weight loss measures will be required.
What is this concept? If you weigh 70kg, you can lose at least 14kg in a year and a half. On a good day, about 30 pounds.
It was based on this data that "Smeaglutide" was approved by the FDA for chronic weight management in June 2021. It is precisely because of the super weight reduction effect, "Smiglutide" is highly sought after in China.
Contact Person: Mrs. Angie Zhang